1. When and where was Nexvet founded?
2. Where is Nexvet located?
3. How is Nexvet’s stock traded?
4. When is Nexvet’s fiscal year-end?
5. Who is the transfer agent for Nexvet?
6. How can I sign up to receive Nexvet press releases and other company information?
7. Where can I find the latest passive foreign investment company (PFIC) statement for Nexvet?
1. When and where was Nexvet founded?
 

Nexvet Australia Pty Ltd, formerly known as Nexvet Biopharma Pty Ltd, or Nexvet Australia, was incorporated in Australia in February 2010. In September 2014, Nexvet Biopharma Limited, a newly-formed Irish private company, became the parent company of Nexvet Australia and its subsidiaries pursuant to a transaction in which all of the holders of ordinary shares, preference shares, restricted share units and options and warrants to purchase ordinary shares of Nexvet Australia exchanged their holdings for equivalent ordinary shares, preference shares, restricted share units or options or warrants to purchase ordinary shares, as applicable, of Nexvet Biopharma Limited.

We refer to this transaction as the “Irish Exchange.” Nexvet Biopharma Limited then re-registered as an Irish public limited company in September 2014. We refer to this re-registration as the “Re-registration” and we refer to the Irish Exchange and the Re-registration collectively as the “Irish Reorganization.” Nexvet Biopharma plc became the parent company of Nexvet Australia pursuant to the Irish Reorganization, and for financial reporting purposes the historical consolidated financial statements of Nexvet Australia became the historical consolidated financial statements of Nexvet Biopharma plc and its subsidiaries as a continuation of the predecessor.



2. Where is Nexvet located?
 
Ireland Principal executive offices Unit 5, Sragh Technology Park
Rahan Road, Tullamore
Co. Offaly, R35 FR98
P: + 353 5793 24522
United States U.S. operations HQ 275 Post Street
4th Floor
San Francisco, CA 94108
Australia Research and development Level 8, 31 Queen Street
Melbourne 3000
Victoria
P: +61 (3) 9610 4400


3. How is Nexvet’s stock traded?
 Nexvet Biopharma is traded on the NASDAQ Global Market under the ticker symbol NVET and its CUSIP number is G6503X109.


4. When is Nexvet’s fiscal year-end?
 June 30.


5. Who is the transfer agent for Nexvet?
 

The transfer agent and registrar for our ordinary shares is American Stock Transfer & Trust Company, LLC.

The transfer agent and registrar’s address is:

6201 Fifteenth Avenue,
Brooklyn, New York 11219

Their contact page is located here.


6. How can I sign up to receive Nexvet press releases and other company information?
 Nexvet invites all interested parties to join its news subscription mailing list here , which as well as key corporate and clinical updates includes a biannual newsletter. For a more comprehensive automatic emailing of every update (including quarterly statements, changes to uploaded files, and more), you can sign up for tailored email alerts here.


7. Where can I find the latest passive foreign investment company (PFIC) statement for Nexvet?
 

The latest PFIC statement for Nexvet can be found here.



Print Page    Email Page    RSS    Email Alerts    IR Contact    Tearsheet 

Nexvet Biopharma

Ireland
Unit 5, Sragh Technology Park
Rahan Road, Tullamore
Co. Offaly, R35 FR98
P: + 353 5793 24522

Australia
Level 8, 31 Queen Street
Melbourne 3000
Victoria
P: +61 (3) 9610 4400

United States
275 Post Street
4th Floor
San Francisco, CA 94108

Email: info@nexvet.com